Cencora profit margin COR
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 0.8%
- Operating margin, 12 months
- 0.9%
- Net margin on a year earlier
- +0.2 pts
- Peer median
- 1.1%
Over the twelve months to Jun 30, 2026, Cencora kept 0.8% of its revenue as net profit, with an operating margin of 0.9% and a gross margin of 4.0%.
Five years earlier its net margin was −1.8%.
The median for 3 medical distribution stocks of a similar size is 1.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 0.5% | 0.8% | 3.6% |
| FY2024 | 0.5% | 0.7% | 3.4% |
| FY2023 | 0.7% | 0.9% | 3.4% |
| FY2022 | 0.7% | 1.0% | 3.5% |
| FY2021 | 0.7% | 1.1% | 3.2% |
| FY2020 | −1.8% | −2.7% | 2.7% |
| FY2019 | 0.5% | 0.6% | 2.9% |
| FY2018 | 1.0% | 0.9% | 2.7% |
| FY2017 | 0.2% | 0.7% | 3.0% |
| FY2016 | 1.0% | 1.0% | 2.9% |
| FY2015 | −0.1% | 0.3% | 2.6% |
| FY2014 | 0.2% | 0.7% | 2.5% |
| FY2013 | 0.5% | 1.0% | 2.9% |
| FY2012 | 0.9% | 1.7% | 3.4% |
| FY2011 | 0.9% | 1.5% | 3.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q3 FY26 | 0.8% | +0.2 pts | 0.9% | |
| Q2 FY26 | 0.8% | +0.2 pts | 0.8% | |
| Q1 FY26 | 0.5% | +0.0 pts | 0.8% | |
| Q4 FY25 | 0.5% | −0.0 pts | 0.8% | |
| Q3 FY25 | 0.6% | −0.1 pts | 0.9% | |
| Q2 FY25 | 0.5% | −0.1 pts | 0.8% | |
| Q1 FY25 | 0.5% | −0.2 pts | 0.7% | |
| Q4 FY24 | 0.5% | −0.2 pts | 0.7% | |
| Q3 FY24 | 0.7% | −0.0 pts | 0.9% | |
| Q2 FY24 | 0.7% | +0.0 pts | 0.9% | |
| Q1 FY24 | 0.7% | −0.0 pts | 0.9% | |
| Q4 FY23 | 0.7% | −0.0 pts | 0.9% |
Against its peers
Companies in Medical - Distribution nearest Cencora's size, closest first, today.
| Company | Profit margin |
|---|---|
| CORCencora | 0.8% |
| CAHCardinal Health | 0.7% |
| MCKMcKesson | 1.1% |
| HSICHenry Schein | 3.0% |
| Peer median | 1.1% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Cencora
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.